The NaBu Effect on Menstruation in Women

Recruiting now · Not applicable

Conditions studied: Menstrual Symptoms

In brief

The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.

Key facts

Study ID

NCT06653426

Run by

Magdy Milad, MD

People needed

15

Starts

2024-10-01

Expected to finish

2026-12-01

Last updated by the study team

2026-04-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older.
• Menstruating regularly or irregularly
• Experiencing menstrual symptoms with an average baseline symptom score of at least 3 on a scale of 0 to 10 for at least one symptom during the initial pre-study rating period.

You may not qualify if…

• Pregnant or breastfeeding patient, attempting or anticipating pregnancy.
• Patient with a history of bloating or a sensitive gut (food intolerance) who needs lower fiber levels.
• Patients with known lactose intolerance, other fermentable oligo-, di-, and mono-saccharides, and polyols (FODMAP) intolerances, or small intestinal bacterial overgrowth (SIBO).
• Patients who would require taking daily antacids for the duration of the study.
• Patients with known or suspected chronic hypertension.
• Post-menopausal patients

Where it is running

• Northwestern University - Northwestern Medicine, Lavin Family Pavilion — Chicago, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.